Notably, KRAS mutated CRC are characterized by limited cytotoxic cells (CTLs, NK cells) infiltration and blunted IFN-γ signaling, a key regulator of PD-L1 expression [160]. This evidence concerns the gene KRAS and colorectal carcinoma.